Allergan Inc. v. Barr Laboratories Inc.
1:09-cv-00333
Overview
Parties
Defendant
Teva Pharmaceutical Industries Ltd Operating Company
Represented By
2 Attorneys ListedPhillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
3 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Plaintiff
Allergan Inc. Operating Company
Represented By
4 Attorneys ListedFish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
U.S. Attorney's Office
The Nemours Building, 1007 Orange Street, Suite 700
Counter Claimant
Barr Laboratories Inc. Operating Company
Represented By
13 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 18 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5688819
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
Filed: 1996-02-22
Issued: 1997-11-18
|
Expired (Term Ended)
Expires: 2014-08-20
|
|
|
US6403649
Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
Filed: 2000-03-06
Issued: 2002-06-11
|
Expired (Term Ended)
Expires: 2020-03-06
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
43
Dispositive
0
Granted
0
Denied
0
Pending / Review
43
Motions by Category
Key Dispositive Motions & Rulings